Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00149760 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of Cognitive-Affective Behavior Therapy for the Treatment of Somatization Disorder
A Phase 2 study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- Phase 2
- Development phase
- 88
- Enrollment target
NCT00149760 is a Phase 2 study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 88 participants.
The verdict
NCT00149760, a Phase 2 study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 88 participants
- Enrollment target
Study Summary
This study will examine the long-term effect of cognitive-affective behavior therapy on the physical symptoms, functioning, and health care utilization of people with somatization disorder.
Interventions
- BEHAVIORAL Augmented Standard Medical Care
- BEHAVIORAL Cognitive-Affective Behavior Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2003-08 |
| Est. Completion | 2010-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00149760
The ClinicalTrials.gov registry entry for NCT00149760 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Augmented Standard Medical Care is the first listed.
NCT00149760 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00149760 about?
NCT00149760 is a clinical study titled "Effectiveness of Cognitive-Affective Behavior Therapy for the Treatment of Somatization Disorder". This study will examine the long-term effect of cognitive-affective behavior therapy on the physical symptoms, functioning, and health care utilization of people with somatization disorder.
What is the current status of trial NCT00149760?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 88 participants. The study started on 2003-08. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00149760?
The interventions under investigation include: Augmented Standard Medical Care (BEHAVIORAL), Cognitive-Affective Behavior Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00149760?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.